Skip to content

Effect of selective segmental ventilation on pulmonary complications and inflammatory factors after thoracoscopic lobectomy

Effect of selective segmental ventilation on pulmonary complications and inflammatory factors after thoracoscopic lobectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044775
Enrollment
Unknown
Registered
2021-03-27
Start date
2021-03-29
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

One-lung Ventilation

Interventions

Group 1:inhaling pure oxygen
Group 2:After rapid pretreatment, the fiO2 of OLV was 60%.
Group 3:FiO2 60% after controlled pulmonary hyperplasia tube drawing.
Group 4:Early postoperative lung extension exercise, balloons were blown in PACU after surgery.
Group 5:After pretreatment, the total FIO of OLV was 260%, and controlled pulmonary inflation at the end of OLV. After the first Blow up a balloon for a day.
Group 6:After pretreatment, the total FiO260% of OLV was achieved, and the OLV was finished 20 cmH2O, 5s at each time, 3s at intervals until lung recovery is satisfactory, and the last pulmonary swell
Group 7:Inhalation of pure oxygen 3 minutes prior to the start of OLV until the end of OLV and after controlled lung inflation FiO260% to extubation. Balloons were blown in PACU after surgery.
Group 8:After pretreatment, the fiO of the whole OLV was 260%, and the controlled increase was achieved at the end of OLV Lung, balloon blowing in PACU after surgery.

Sponsors

Department of Anesthesiology, Nanfang Hospital Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 90 adult patients undergoing elective thoracoscopic lobectomy; 2. Aged from 18 to 70 years; 3. American association of anesthesiologists classified as grade I or II; 4. no history of thoracic surgery and radiotherapy; 5. no complication of other malignant tumors; 6. non-small cell lung cancer; 7. no special abnormality in preoperative pulmonary function examination.

Exclusion criteria

Exclusion criteria: 1. Chest X-ray showed that the transverse diameter of the trachea at the clavicular end of the sternum was less than 11mm; 2. Bronchial anatomical abnormalities were found by preoperative fiberoptic bronchoscopy; 3. Patients with inverted whole organs; 4. Cardiac function class III or IV; 5. Heart-related diseases; 6. Thrombocytopenia; 7. History of anesthetic allergy; 8. Family history of malignant hyperthermia; 9. Predictable and unpredictable difficult airway: Mallampati airway grade III or above, temporomandibular joint ankylosis or mouth opening difficulty, unable to insert DLT successfully. 10. Pregnancy or puerperium; 11. Peripheral vascular disease; 12. Coagulation dysfunction; 13. Patients with large amount of blood loss and blood transfusion during operation, patients with cardiopulmonary resuscitation; 14. Patients who need large dose of vasoactive drugs to maintain circulation; 15. Patients who cannot be extubated after operation and need to continue to use ventilator-assisted ventilation; 16. Patients who need secondary intubation or secondary operation.

Design outcomes

Primary

MeasureTime frame
incidence of postoperative pulmonary complications;

Secondary

MeasureTime frame
postoperative chest tube indwelling time;postoperative hospital stay;

Countries

China

Contacts

Public ContactYe Jing

Department of Anesthesiology, Nanfang Hospital Southern Medical University

w1605@163.com+86 18922363868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026